The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 3 rounds in the feed, most often in Biotech.
Mass Medical Angels (MA2) is a seed stage investor group exclusively focused on life science and healthcare investments.
Angel groupmassmedangels.comRounds from 2017-07-17 to 2021-05-03
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Astrocyte Pharmaceuticals Inc. A clinical-stage biotechnology company developing first-in-class cerebroprotective therapies for concussion, traumatic brain injury (TBI) and stroke | Series A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $6M | 2021-05-03 | [ PART ] |
Pre-A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. |
| $2.3M |
| 2018-06-06 |
| [ PART ] |
Astrocyte Pharmaceuticals Inc. A clinical-stage biotechnology company developing first-in-class cerebroprotective therapies for concussion, traumatic brain injury (TBI) and stroke | Seed Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $2.4M | 2017-07-17 | [ PART ] |